Leukemia & Lymphoma
Volume 64, 2023 - Issue 3
Original Articles
Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice
Maria Julia Montoroa Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, Spain
https://orcid.org/0000-0001-9532-7417View further author information
https://orcid.org/0000-0001-9532-7417View further author information, , , Teresa Bernal del Castillod Hospital Universitario Central de Asturias, Oviedo, Spainhttps://orcid.org/0000-0002-2338-513XView further author information
https://orcid.org/0000-0002-2338-513XView further author information, Mar Tormoe Hospital Clínico Universitario de Valencia e Instituto de Investigación INCLIVA, Valencia, Spainhttps://orcid.org/0000-0001-9622-1649View further author information
https://orcid.org/0000-0001-9622-1649View further author information, , , , , María Díez-Campeloj Hospital Clínico Universitario de Salamanca, Salamanca, Spainhttps://orcid.org/0000-0002-1467-6779View further author information
https://orcid.org/0000-0002-1467-6779View further author information, Fernando Ramosk Hospital Universitario de León, León, Spainhttps://orcid.org/0000-0002-4991-2655View further author information
https://orcid.org/0000-0002-4991-2655View further author information, , , , , , , , David Valcárcela Department of Hematology, Hospital Universitari Vall d´Hebron, Barcelona, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-8747-078XView further author information
https://orcid.org/0000-0002-8747-078XView further author information & on behalf of ERASME study group show all